Remodulin

Remodulin is a brand name of treprostinil, approved by the FDA in the following formulation(s):

REMODULIN (treprostinil sodium - injectable; iv (infusion)-sc)

• 
  Manufacturer: UNITED THERAP
  
  Approval date: May 21, 2002
  
  Strength(s): 10MG/ML ^[RLD], 1MG/ML, 2.5MG/ML, 5MG/ML
  

Has a generic version of Remodulin been approved?

No. There is currently no therapeutically equivalent version of Remodulin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Remodulin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method of treating pulmonary hypertension with benzidine prostaglandins
  Patent 5,153,222
  Issued: October 6, 1992
  Inventor(s): Tadepalli; Anjaneyulu S. & Long; Walker A. & Crow; James W. & Klein; Kenneth B.
  Assignee(s): Burroughs Wellcome Co.
  The present invention is concerned with methods for the prophylaxis, treatment and diagnosis of pulmonary hypertension which comprise the administrative of an effective amount of a compound of formula (I) ##STR1## wherein a is an integer of from 1 to 3; X and Y, which may be the same or different, are selected from --O-- and --CH.sub.2 --; R is --(CH.sub.2).sub.5 R.sup.1 wherein R.sup.1 is hydrogen or methyl, or R is cyclohexyl, or R is --CH(CH.sub.3)CH.sub.2 C.tbd.CCH.sub.3 ; and the dotted line represents an optional double bond; or of a physiologically acceptable salt or acid derivative thereof. Medicaments and diagnostic aids for use in the methods of the invention are also within the scope of the invention.
  
  Patent expiration dates:
  
  
  • October 6, 2014
    
    ✓ 
    Patent use: TREATMENT OF PULMONARY HYPERTENSION WITH UT-15
  
  



• 
  Process for stereoselective synthesis of prostacyclin derivatives
  Patent 6,765,117
  Issued: July 20, 2004
  Inventor(s): Robert M.; Moriarty & Raju; Penmasta & Liang; Guo & Munagala S.; Rao & James P.; Staszewski
  Assignee(s): United Therapeutic Corporation
  An improved method is described for making 9-deoxy-PGF1-type compounds. In contrast to the prior art, the method is stereoselective and requires fewer steps than the known methods for making these compounds. The invention also relates to novel intermediates prepared during the synthesis of the 9-deoxy-PGF1-type compounds.
  
  Patent expiration dates:
  
  
  • October 24, 2017
    
    ✓ 
    Drug substance
  
  



• 
  Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
  Patent 7,999,007
  Issued: August 16, 2011
  Inventor(s): Jeffs; Roger & Zaccardelli; David
  Assignee(s): United Therapeutics Corporation
  Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less than about 4.5 with low buffer capacity. Methods of their use in reducing the occurrence of blood stream infections in a mammal is also provided.
  
  Patent expiration dates:
  
  
  • March 29, 2029
    
    ✓ 
    Patent use: ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH STERILE WATER FOR INJECTION, 0.9% SODIUM CHLORIDE INJECTION, OR FLOLAN STERIILE DILUENT FOR INJECTION PRIOR TO ADMINISTRATION
    ✓ 
    Drug product
  
  

See also...

• Remodulin Solution Consumer Information (Wolters Kluwer)
• Remodulin Consumer Information (Cerner Multum)
• Remodulin Advanced Consumer Information (Micromedex)
• Remodulin AHFS DI Monographs (ASHP)
• Treprostinil Inhalation Solution Consumer Information (Wolters Kluwer)
• Treprostinil Solution Consumer Information (Wolters Kluwer)
• Treprostinil Consumer Information (Cerner Multum)
• Treprostinil inhalation Consumer Information (Cerner Multum)
• Treprostinil injection Consumer Information (Cerner Multum)
• Treprostinil Inhalation Advanced Consumer Information (Micromedex)
• Treprostinil Injection Advanced Consumer Information (Micromedex)
• Treprostinil Sodium AHFS DI Monographs (ASHP)